BRIEF published on 03/12/2026 at 07:30, 14 days 13 hours ago Closure of pharmaceutical production at Bichsel Pharmaceutical Production Galenica AG Social Plan Bichsel Closure Customer Transition
BRIEF published on 03/12/2026 at 07:30, 14 days 13 hours ago Galenica's Bichsel to Close Pharmaceutical Operations Customer Support Social Plan Bichsel Closure Job Redundancies Galenica Strategy
PRESS RELEASE published on 03/12/2026 at 07:25, 14 days 13 hours ago Consultation process at Bichsel completed Bichsel completes consultation process, to close pharmaceutical manufacturing operations with reduced job redundancies. Galenica's subsidiary to focus on home care services Galenica Pharmaceutical Manufacturing Consultation Process Redundancies Bichsel
BRIEF published on 03/10/2026 at 06:45, 16 days 14 hours ago Galenica records solid growth in 2025 and adjusts its forecasts EBIT Growth Diagnosis Galenica Pharmacies
BRIEF published on 03/10/2026 at 06:45, 16 days 14 hours ago Galenica Reports Strong 2025 Results and Raises Mid-Term Guidance Sales Growth EBIT Increase Healthcare Services Galenica Results Diagnostics Expansion
PRESS RELEASE published on 03/10/2026 at 06:40, 16 days 14 hours ago Galenica achieves strong annual result and increases mid-term guidance Galenica achieves strong annual results, increasing sales by 5.5% to CHF 4,135.6 million in 2025. Mid-term EBIT guidance raised to CHF 270 million by 2027 Sales Increase Annual Results EBIT Growth Galenica Mid-term Guidance
BRIEF published on 02/24/2026 at 06:45, 1 month 2 days ago Galenica Restructures Bichsel with Focus on Home Care Services Home Care Services Galenica AG Bichsel Restructuring Job Impact Financial Effects
BRIEF published on 02/24/2026 at 06:45, 1 month 2 days ago Galenica is repositioning its subsidiary Bichsel towards home healthcare Home Care Galenica Social Plan Bichsel Production Closed
PRESS RELEASE published on 02/24/2026 at 06:40, 1 month 2 days ago Galenica focuses Bichsel’s business on home care services Galenica's subsidiary Bichsel to focus on home care services and discontinue pharmaceutical production by end of 2026, affecting 170 jobs. Galenica strengthens strategy implementation Galenica Pharmaceutical Production Home Care Services Strategy Implementation Bichsel
BRIEF published on 01/22/2026 at 06:45, 2 months 4 days ago Galenica AG Sees Record Sales Growth to Over CHF 4 Billion Financial Performance Sales Growth Galenica Pharmacy Expansion Diagnostics Introduction
Published on 03/26/2026 at 21:00, 15 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 21:00, 15 minutes ago Rocky Shore Closes Acquisition of Additional Mining Claims
Published on 03/26/2026 at 16:20, 4 hours 55 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 8 hours 15 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 20:48, 27 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 1 hour 55 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 2 hours 6 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 2 hours 58 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 07:30, 13 hours 45 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
